<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 28 Sep 2026 17:01:13 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>PreveCeutical plans private placement to raise up to $600,000</title>
   <link>http://www.streetinsider.com/Equity+Offerings/PreveCeutical+plans+private+placement+to+raise+up+to+%24600%2C000/27115345.html</link>
   <description>

&lt;p&gt;PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) announced a non-brokered private placement of up to 20,000,000 units at $0.03 per unit, seeking gross proceeds of up to $600,000.&lt;/p&gt;

&lt;p&gt;Each unit consists of one common share and one-half of one share purchase warrant. Each whole warrant allows the holder to purchase one additional share at $0.06 per share for two years from closing. The warrants may expire early if the closing price of the company's common shares on the Canadian Securities Exchange reaches $0.11 or higher for at least 10 consecutive trading days and a notice of acceleration is issued.&lt;/p&gt;

&lt;p&gt;According</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/PreveCeutical+plans+private+placement+to+raise+up+to+%24600%2C000/27115345.html</guid>
   <pubDate>Mon, 28 Sep 2026 17:01:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PreveCeutical plans private placement to raise up to $600,000</title>
   <link>http://www.streetinsider.com/Equity+Offerings/PreveCeutical+plans+private+placement+to+raise+up+to+%24600%2C000/27115345.html</link>
   <description>

&lt;p&gt;PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) announced a non-brokered private placement of up to 20,000,000 units at $0.03 per unit, seeking gross proceeds of up to $600,000.&lt;/p&gt;

&lt;p&gt;Each unit consists of one common share and one-half of one share purchase warrant. Each whole warrant allows the holder to purchase one additional share at $0.06 per share for two years from closing. The warrants may expire early if the closing price of the company's common shares on the Canadian Securities Exchange reaches $0.11 or higher for at least 10 consecutive trading days and a notice of acceleration is issued.&lt;/p&gt;

&lt;p&gt;According</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/PreveCeutical+plans+private+placement+to+raise+up+to+%24600%2C000/27115345.html</guid>
   <pubDate>Mon, 28 Sep 2026 17:01:13 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PreveCeutical Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - &lt;b&gt;PreveCeutical Medical Inc.&amp;#160;&lt;/b&gt;(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0)&lt;b&gt;&amp;#160;(the &quot;Company&quot; or &quot;PreveCeutical&quot;)&lt;/b&gt;, is pleased to announce a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) of up to 20,000,000 units (each, a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) in the capital of the Company at a price of $0.03 per Unit for gross proceeds of up to $600,000. Each Unit consists of one (1) common share of the Company (each, a &quot;&lt;b&gt;Share&lt;/b&gt;&quot;) and one-half (1/2) of one Share purchase warrant (each whole warrant, a &quot;&lt;b&gt;Warrant&lt;/b&gt;&quot;). Each Warrant entitles the holder thereof to purchase an additional Share (each, a &quot;&lt;b&gt;Warrant Share&lt;/b&gt;&quot;)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</guid>
   <pubDate>Mon, 28 Sep 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PreveCeutical Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Newsfile/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - &lt;b&gt;PreveCeutical Medical Inc.&amp;#160;&lt;/b&gt;(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0)&lt;b&gt;&amp;#160;(the &quot;Company&quot; or &quot;PreveCeutical&quot;)&lt;/b&gt;, is pleased to announce a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) of up to 20,000,000 units (each, a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) in the capital of the Company at a price of $0.03 per Unit for gross proceeds of up to $600,000. Each Unit consists of one (1) common share of the Company (each, a &quot;&lt;b&gt;Share&lt;/b&gt;&quot;) and one-half (1/2) of one Share purchase warrant (each whole warrant, a &quot;&lt;b&gt;Warrant&lt;/b&gt;&quot;). Each Warrant entitles the holder thereof to purchase an additional Share (each, a &quot;&lt;b&gt;Warrant Share&lt;/b&gt;&quot;)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</guid>
   <pubDate>Mon, 28 Sep 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PreveCeutical Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - &lt;b&gt;PreveCeutical Medical Inc.&amp;#160;&lt;/b&gt;(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0)&lt;b&gt;&amp;#160;(the &quot;Company&quot; or &quot;PreveCeutical&quot;)&lt;/b&gt;, is pleased to announce a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) of up to 20,000,000 units (each, a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) in the capital of the Company at a price of $0.03 per Unit for gross proceeds of up to $600,000. Each Unit consists of one (1) common share of the Company (each, a &quot;&lt;b&gt;Share&lt;/b&gt;&quot;) and one-half (1/2) of one Share purchase warrant (each whole warrant, a &quot;&lt;b&gt;Warrant&lt;/b&gt;&quot;). Each Warrant entitles the holder thereof to purchase an additional Share (each, a &quot;&lt;b&gt;Warrant Share&lt;/b&gt;&quot;)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</guid>
   <pubDate>Mon, 28 Sep 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PreveCeutical Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Newsfile/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - &lt;b&gt;PreveCeutical Medical Inc.&amp;#160;&lt;/b&gt;(CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0)&lt;b&gt;&amp;#160;(the &quot;Company&quot; or &quot;PreveCeutical&quot;)&lt;/b&gt;, is pleased to announce a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) of up to 20,000,000 units (each, a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) in the capital of the Company at a price of $0.03 per Unit for gross proceeds of up to $600,000. Each Unit consists of one (1) common share of the Company (each, a &quot;&lt;b&gt;Share&lt;/b&gt;&quot;) and one-half (1/2) of one Share purchase warrant (each whole warrant, a &quot;&lt;b&gt;Warrant&lt;/b&gt;&quot;). Each Warrant entitles the holder thereof to purchase an additional Share (each, a &quot;&lt;b&gt;Warrant Share&lt;/b&gt;&quot;)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/PreveCeutical+Announces+Non-Brokered+Private+Placement/27115337.html</guid>
   <pubDate>Mon, 28 Sep 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES &amp;amp; OBESITY DUAL GENE THERAPY PROGRAM</title>
   <link>http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/ca.bc.vancvr&quot; idsrc=&quot;xmltag.org&quot; &gt;VANCOUVER, BC&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Dec. 4, 2023&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -&lt;b&gt; &lt;span value=&quot;CNSX:PREV&quot; idsrc=&quot;xmltag.org&quot; &gt;PreveCeutical Medical Inc.&lt;/span&gt; (the &amp;quot;Company&amp;quot; or &amp;quot;PreveCeutical&amp;quot;)&lt;/b&gt; (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and &lt;i&gt;in vitro&lt;/i&gt; validated Smart-siRNA sequences, which when paired with our proprietary bioresponsive lipid-nanoparticulate delivery systems (US patent no. 11,566,044) effectively target the &lt;i&gt;PTPN1&lt;/i&gt; gene.&lt;/p&gt;

    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
    </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/PREVECEUTICAL+INITIATES+PREPARATION+OF+PROOF-OF-CONCEPT+PRECLINICAL+STUDY+FOR+ITS+DIABETES+%26amp%3B+OBESITY+DUAL+GENE+THERAPY+PROGRAM/22484191.html</guid>
   <pubDate>Mon, 04 Dec 2023 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
  <item>
   <title>New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;NEW YORK, Sept.  22, 2023  (GLOBE NEWSWIRE) -- FMW Media&amp;apos;s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street&amp;apos;s televised platforms on &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=PzkgYFGRie9RulvBaDvp7NktDrwqme_Nczyxo0X5EdS93RR9wj0zmsKlmBwYWPoOvGjIOtZbnDIPwcGhnBUabKzIawGpcmvWFDQexoDHikA=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Newsmax&lt;/a&gt; and the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=FhtlNP1Qt3WPqNu6IkeyyeP3vTQ54mCgIRREb-zxcPE1ZSmltWGr-abrtYSs7d8U5psjrPAosOzqYrjwl8BPrqNnAYpTDu-pAYCZO3fjBPM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;FOX Business Network&lt;/a&gt;.&lt;/p&gt;    &lt;p align=&quot;start&quot;&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=nzGV6etJXb5QAhILOxk1w5DZYBhnPSdcKNiFi7W50Ce8JEfQnhy7gGs4R7ZzKkHUgUEiMcny7T3EIRZwEuADThk4Vzyj9MZWgJMQH7FHe8k=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;&lt;em&gt;New to The Street&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt; airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+Announces+its+Five+Corporate+Interviews%2C+airings+on+Newsmax+and+FOX+Business+Network/22189521.html</guid>
   <pubDate>Fri, 22 Sep 2023 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">18H</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20248349</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20398796</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AREB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GDT0</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00635883</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00783833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08381727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31501575</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37002047</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41609019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.52737805</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PREV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PRVCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SKUR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOPA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWISF</category>
   	  </item>
 </channel>
</rss>
